INTRODUCTION: Bipolar disorder is associated with functional impairment across a number of domains, including health-related quality of life (HRQOL). Many patients are treated exclusively in primary care (PC) settings, yet little is known how HRQOL outcomes compare between PC and community mental health (CMH) settings. This study aimed to explore the correlates of HRQOL across treatment settings using baseline data from a multisite, randomized controlled trial for adults with bipolar disorder. METHODS:HRQOL was measured using the SF-12 physical (PCS) and mental (MCS) composite scale scores. Independent sample t-tests were calculated to compare differences in HRQOL between settings. Multivariate regression models then examined the effect of treatment setting on HRQOL, adjusting for covariate demographic factors, mood symptoms (Internal State Scale), hazardous drinking (AUDIT-C), and substance abuse. RESULTS: A total of 384 enrolled participants completed baseline surveys. MCS and PCS scores reflected similar impairment in HRQOL across PC and CMH settings (p=0.98 and p=0.49, respectively). Depressive symptoms were associated with lower MCS scores (B=-0.68, p<0.001) while arthritis/chronic pain was strongly related to lower PCS scores (B=-5.23, p<0.001). LIMITATIONS: This study lacked a formal diagnostic interview, relied on cross-sectional self-report, and sampled from a small number of sites in two states. DISCUSSION: Participants reported similar impairments in both mental and physical HRQOL in PC and CMH treatment settings, emphasizing the need for integrated care for patients with bipolar disorder regardless of where they present for treatment. Published by Elsevier B.V.
RCT Entities:
INTRODUCTION:Bipolar disorder is associated with functional impairment across a number of domains, including health-related quality of life (HRQOL). Many patients are treated exclusively in primary care (PC) settings, yet little is known how HRQOL outcomes compare between PC and community mental health (CMH) settings. This study aimed to explore the correlates of HRQOL across treatment settings using baseline data from a multisite, randomized controlled trial for adults with bipolar disorder. METHODS: HRQOL was measured using the SF-12 physical (PCS) and mental (MCS) composite scale scores. Independent sample t-tests were calculated to compare differences in HRQOL between settings. Multivariate regression models then examined the effect of treatment setting on HRQOL, adjusting for covariate demographic factors, mood symptoms (Internal State Scale), hazardous drinking (AUDIT-C), and substance abuse. RESULTS: A total of 384 enrolled participants completed baseline surveys. MCS and PCS scores reflected similar impairment in HRQOL across PC and CMH settings (p=0.98 and p=0.49, respectively). Depressive symptoms were associated with lower MCS scores (B=-0.68, p<0.001) while arthritis/chronic pain was strongly related to lower PCS scores (B=-5.23, p<0.001). LIMITATIONS: This study lacked a formal diagnostic interview, relied on cross-sectional self-report, and sampled from a small number of sites in two states. DISCUSSION: Participants reported similar impairments in both mental and physical HRQOL in PC and CMH treatment settings, emphasizing the need for integrated care for patients with bipolar disorder regardless of where they present for treatment. Published by Elsevier B.V.
Authors: Amy M Kilbourne; Mary Spink Neumann; Jeanette Waxmonsky; Mark S Bauer; Hyungin Myra Kim; Harold Alan Pincus; Marshall Thomas Journal: Psychiatr Serv Date: 2012-03 Impact factor: 3.084
Authors: Laura A Bajor; Zongshan Lai; David E Goodrich; Christopher J Miller; Robert B Penfold; Hyungjin Myra Kim; Mark S Bauer; Amy M Kilbourne Journal: J Affect Disord Date: 2012-09-27 Impact factor: 4.839
Authors: Waguih William IsHak; Kimberly Brown; San San Aye; Maria Kahloon; Shakiba Mobaraki; Rose Hanna Journal: Bipolar Disord Date: 2012-02 Impact factor: 6.744
Authors: Robin Haring; You-Shan Feng; Jörn Moock; Henry Völzke; Marcus Dörr; Matthias Nauck; Henri Wallaschofski; Thomas Kohlmann Journal: BMC Med Res Methodol Date: 2011-07-12 Impact factor: 4.615
Authors: Joseph M Cerimele; Lydia A Chwastiak; Ya-Fen Chan; David A Harrison; Jürgen Unützer Journal: J Gen Intern Med Date: 2013-12 Impact factor: 5.128
Authors: Kristen M Abraham; Christopher J Miller; Denis G Birgenheir; Zongshan Lai; Amy M Kilbourne Journal: J Nerv Ment Dis Date: 2014-08 Impact factor: 2.254
Authors: Ashli Owen-Smith; Christine Stewart; Musu M Sesay; Sheryl M Strasser; Bobbi Jo Yarborough; Brian Ahmedani; Lisa R Miller-Matero; Stephen C Waring; Irina V Haller; Beth E Waitzfelder; Stacy A Sterling; Cynthia I Campbell; Rulin C Hechter; John E Zeber; Laurel A Copeland; Jeffrey F Scherrer; Rebecca Rossom; Greg Simon Journal: BMC Psychiatry Date: 2020-01-31 Impact factor: 3.630
Authors: Lucas Anyayo; Scholastic Ashaba; Mark Mohan Kaggwa; Samuel Maling; Etheldreda Nakimuli-Mpungu Journal: Health Qual Life Outcomes Date: 2021-03-10 Impact factor: 3.186